Piper Sandler lowered the firm’s price target on Hain Celestial to $8 from $11 and keeps a Neutral rating on the shares. The firm notes Hain’s Q3 top-line momentum was marked by continued challenges in Personal Care and Baby Formula, which look set to extend into 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HAIN: